In recent years, there has been renewed interest in psychedelic treatment for a variety of medical conditions ranging from depression to trauma, and even dementia, which has left countless people searching for real recovery. This exciting research is challenging the limits of what’s possible. Psychedelic compounds, once misunderstood or dismissed, are now being studied for their ability to promote neuroplasticity, neurogenesis, and reduction in inflammation.

In this episode of Trending Health, we’re joined by three individuals who are passionate about the growing clinical utility of psychedelic treatments. However, with these treatments, it is critical to think about how to put the patient in the middle and engaged with their treatment to help ensure optimal outcomes:

• Varun Renjen, a partner at Inizio Putnam and a physician who has been supporting biopharma clients as a strategy consultant for the past 15 years; especially in neurological diseases;
• Steve Levine, Chief Patient Officer at Compass Pathways and board-certified psychiatrist who has spent his career working to improve people’s lives through creating access to innovation in mental health;
• Daniel Carcillo, a former NHL hockey player who developed Traumatic Brain Injury (TBI) and depression from the sport who has been successfully treated with psychedelic therapy as a patient and is an advocate for access to psychedelic treatment for brain injury

Tags: healthcare, psychedelics, psilocybin, mushrooms, concussions, traumatic brain injuries, depression, mental health, medical affairs

Panel – Varun Renjen, Steve Levine, Daniel Carcillo

Recording & Editing – Mike Liberto

For additional discussion, please contact us at TrendingHealth.com.

The traditional path to patients is being rewritten. As affordability pressures rise and patient expectations shift, life sciences companies are rethinking the middle — moving beyond payers, providers, and pharmacies to create direct, digital pathways that meet patients where they are.

In this episode, host Adrea Cope is joined by Colleen Ferlotti and Rupa Mehta to unpack the rapid rise of Direct-to-Patient (DTP) models: what’s fueling the shift, how leaders are navigating regulatory and operational complexity, and why success depends on designing with both discipline and empathy.

To learn more about how we can help your team navigate these changing landscapes, please reach out to Mike.Zapiec@vynamic.com

Podcast Tags: healthcare, life sciences, life sciences marketing, direct to patient, patient centricity, digital health

Source Links:

Triangle Insights Group (August 2025). The Direct-to-Patient Channel in Pharma: A Practical Guide to Protect GTN, Expand Access, and Improve Patient Experience.

Panel – Adrea Cope, Colleen Ferlotti, Rupa Mehta

Research & Production – Adrea Cope, Colleen Ferlotti, Rupa Mehta, Peter Svalbe, Mike Zapiec

Recording & Editing – Mike Liberto

For additional discussion, please contact us at TrendingHealth.com. 

As Gen Z steps into the healthcare workforce, they’re bringing new expectations for authenticity, technology, and purpose-driven brands. The old pharma playbook? Invisible to this generation.

In this episode of Trending Health, host Adrea Cope sits down with Carolyn Frantz and Mindy McGrath to explore how life sciences marketers can evolve to engage the next generation of HCPs and patients — from short-form content and streaming-first strategies to redefining the pharma rep of the future.

To learn more about how we can help your team navigate these changing landscapes, please reach out to Carolyn.Frantz@vynamic.com or Mike.Zapiec@vynamic.com

Podcast Tags: healthcare, life sciences, life sciences marketing, Gen Z, digital health, brand authenticity

Source Links:

• Gen Z more likely to report mental health concerns
• Generation X Faces Higher Cancer Rates Than Boomers: Study

Panel – Adrea Cope, Carolyn Frantz, Mindy McGrath

Research & Production – Adrea Cope, Carolyn Frantz, Hannah Yee, Mike Zapiec

Recording & Editing – Mike Liberto, Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com.